Indivior Pharmaceuticals, Inc. (INDV) on GreekSoup https://greeksoup.ai/stocks/us/indv/ Every dated entry in the public record on Indivior Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Indivior Pharmaceuticals, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-10-06:1b3f9e8e70Tue, 06 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: Schedule 13G filed by Millennium Management LLC, 5.4% of the classhttps://greeksoup.ai/stocks/us/indv/holders/us:INDV:schedule-13:2026-09-30:a67d222f76Wed, 30 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 10,413,493 shares at the 30 September 2026 settlement, 5.26 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-09-30:22671fd271Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-09-17:b1d66849e7Thu, 17 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 8-K: termination of a material agreementhttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-09-15:a6bbb5fc4eTue, 15 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 11,172,005 shares at the 15 September 2026 settlement, 5.70 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-09-15:9274eaabaaTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 11,298,896 shares at the 31 August 2026 settlement, 5.71 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-08-31:82a15f897bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed S-4: s-4https://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-08-28:caa4e06d65Fri, 28 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: Anderson Woodrow D (Chief Accounting Officer) bought 1,500 shares at $35.69 on 27 August 2026, $53,535https://greeksoup.ai/stocks/us/indv/insiders/us:INDV:insider:2026-08-27:f19d8fe5bbThu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 10,447,376 shares at the 14 August 2026 settlement, 3.27 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-08-14:94bbff01a9Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: Anderson Woodrow D (Chief Accounting Officer) bought 1,500 shares at $36.28 on 5 August 2026, $54,420https://greeksoup.ai/stocks/us/indv/insiders/us:INDV:insider:2026-08-05:c19611e043Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. Q2 FY2026 results: revenue $343 million, net income $122 millionhttps://greeksoup.ai/stocks/us/indv/results/fy2026-q2/us:INDV:result:2026-08-03:57b24c6e12Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-08-03:208768d6c7Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-08-03:6bbaa92810Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-08-03:f7d2657d7cMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc. filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/indv/filings/us:INDV:filing:2026-08-03:e6b50ff59dMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 10,877,755 shares at the 31 July 2026 settlement, 7.13 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-07-31:eeee0be873Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Indivior Pharmaceuticals, Inc.: short interest 11,277,025 shares at the 15 July 2026 settlement, 7.58 days to coverhttps://greeksoup.ai/stocks/us/indv/short-interest/us:INDV:short-interest:2026-07-15:571c3f207bWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>